John Collinge
Gründer bei D-Gen Ltd.
Aktive Positionen von John Collinge
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
D-Gen Ltd.
 D-Gen Ltd. BiotechnologyHealth Technology D-Gen Ltd. develops technologies for detection and prevention of prion diseases. The firm offers services that include prion reduction studies, in-process validation and contract sample testing. The company was founded in by John Collinge on November 19, 1998 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 19.11.1998 | - |
| Gründer | 19.11.1998 | - | |
| University College London | Corporate Officer/Principal | - | - |
| The National Hospital for Neurology & Neurosurgery | Corporate Officer/Principal | - | - |
Karriereverlauf von John Collinge
Ehemalige bekannte Positionen von John Collinge
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Corporate Officer/Principal | - | - |
| Imperial College London | Corporate Officer/Principal | - | - |
Statistik
International
| Vereinigtes Königreich | 6 |
Operativ
| Corporate Officer/Principal | 4 |
| Director/Board Member | 1 |
| Founder | 1 |
Sektoral
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
D-Gen Ltd.
D-Gen Ltd. BiotechnologyHealth Technology D-Gen Ltd. develops technologies for detection and prevention of prion diseases. The firm offers services that include prion reduction studies, in-process validation and contract sample testing. The company was founded in by John Collinge on November 19, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
| The National Hospital for Neurology & Neurosurgery |
- Börse
- Insiders
- John Collinge
- Erfahrung
